Ebola Vaccine Trials Could Start This Year
As Ebola cases rise in Congo and Uganda, vaccine developers are accelerating efforts to combat the rare Bundibugyo strain. IAVI CEO Mark Feinberg says a
As Ebola cases rise in Congo and Uganda, vaccine developers are accelerating efforts to combat the rare Bundibugyo strain. IAVI CEO Mark Feinberg says a candidate vaccine could enter human trials by year-end.
More on Bloomberg Television and Markets Like this video? Subscribe and turn on notifications so you don't miss any videos from Bloomberg Markets & Finance
Visit for business news & analysis, up-to-the-minute market data, features, profiles and more. Connect with Bloomberg Television on Connect with Bloomberg Business on TikTok Reddit
More from Bloomberg Bloomberg Radio Bloomberg Surveillance Bloomberg Politics Bloomberg Originals Watch more on Bloomberg Technology Bloomberg Originals Bloomberg Quicktake Bloomberg Espanol Bloomberg Podcasts
The BriefWire